Jurczak M, Druszczynska M
Pathogens. 2025; 14(2).
PMID: 40005571
PMC: 11857995.
DOI: 10.3390/pathogens14020196.
Dias H, Fu J, Luck T, Wolfe G, Hostetter E, Ng N
Sci Rep. 2024; 14(1):17611.
PMID: 39080423
PMC: 11289084.
DOI: 10.1038/s41598-024-67905-x.
Rahman M, Gelanew T, Barman S, Nainu F
Front Immunol. 2024; 15:1440061.
PMID: 39055719
PMC: 11270504.
DOI: 10.3389/fimmu.2024.1440061.
Kuhtreiber W, Hostetter E, Wolfe G, Vaishnaw M, Goldstein R, Bulczynski E
iScience. 2024; 27(6):109881.
PMID: 39055605
PMC: 11270028.
DOI: 10.1016/j.isci.2024.109881.
Noval Rivas M, Rosser C, Arditi M
Bladder Cancer. 2024; 7(2):121-131.
PMID: 38994533
PMC: 11181712.
DOI: 10.3233/BLC-201529.
Expanded Scope of Bacillus Calmette-Guerin (BCG) Vaccine Applicability in Disease Prophylaxis, Diagnostics, and Immunotherapeutics.
Adesanya O, Uche-Orji C, Adedeji Y, Joshua J, Adesola A, Chukwudike C
Infect Microbes Dis. 2024; 2(4):144-150.
PMID: 38630099
PMC: 7769055.
DOI: 10.1097/IM9.0000000000000040.
Immune Cells, Gut Microbiota, and Vaccines: A Gender Perspective.
Rio P, Caldarelli M, Chiantore M, Ocarino F, Candelli M, Gasbarrini A
Cells. 2024; 13(6.
PMID: 38534370
PMC: 10969451.
DOI: 10.3390/cells13060526.
Effects of Neonatal BCG-Japan Versus BCG-Russia Vaccination on Overall Mortality and Morbidity: Randomized Controlled Trial From Guinea-Bissau (BCGSTRAIN II).
Schaltz-Buchholzer F, Nielsen S, Sorensen M, Stjernholm E, Fabricius R, Umbasse P
Open Forum Infect Dis. 2024; 11(3):ofae057.
PMID: 38500576
PMC: 10946234.
DOI: 10.1093/ofid/ofae057.
Can earlier BCG-Japan and OPV vaccination reduce early infant mortality? A cluster-randomised trial in Guinea-Bissau.
Thysen S, Borges I, Martins J, Stjernholm A, Hansen J, da Silva L
BMJ Glob Health. 2024; 9(2).
PMID: 38350670
PMC: 10862335.
DOI: 10.1136/bmjgh-2023-014044.
Development of a fast and precise potency test for BCG vaccine viability using flow cytometry compared to MTT and colony-forming unit assays.
Moghawry H, Rashed M, Gomaa K, AbdelGhani S, Dishisha T
Sci Rep. 2023; 13(1):11606.
PMID: 37464014
PMC: 10354009.
DOI: 10.1038/s41598-023-38657-x.
Previous BCG vaccination is associated with less severe clinical progression of COVID-19.
Pereira S, Barreto F, de Souza R, de Souza Teles Santos C, Pereira M, Paixao E
BMC Med. 2023; 21(1):145.
PMID: 37055776
PMC: 10099006.
DOI: 10.1186/s12916-023-02859-x.
Characterization of "Off-Target" Immune Modulation Induced by Live Attenuated Yellow Fever Vaccine.
Xiang J, Chang Q, McLinden J, Bhattarai N, Welch J, Kaufman T
J Infect Dis. 2023; 229(3):786-794.
PMID: 36994927
PMC: 10938199.
DOI: 10.1093/infdis/jiad086.
Evaluating the Protective Effect of Intravesical Bacillus Calmette-Guerin against SARS-CoV-2 in Non-Muscle Invasive Bladder Cancer Patients: A Multicenter Observational Trial.
Hurle R, Soria F, Contieri R, Avolio P, Mancon S, Lazzeri M
Cancers (Basel). 2023; 15(5).
PMID: 36900409
PMC: 10000457.
DOI: 10.3390/cancers15051618.
BCG-induced trained immunity: history, mechanisms and potential applications.
Chen J, Gao L, Wu X, Fan Y, Liu M, Peng L
J Transl Med. 2023; 21(1):106.
PMID: 36765373
PMC: 9913021.
DOI: 10.1186/s12967-023-03944-8.
Gender differences in tuberculosis incidence rates-A pooled analysis of data from seven high-income countries by age group and time period.
Peer V, Schwartz N, Green M
Front Public Health. 2023; 10:997025.
PMID: 36703824
PMC: 9873377.
DOI: 10.3389/fpubh.2022.997025.
Non-Specific Effects of Bacillus Calmette-Guérin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Trunk G, Davidovic M, Bohlius J
Vaccines (Basel). 2023; 11(1).
PMID: 36679966
PMC: 9866113.
DOI: 10.3390/vaccines11010121.
Therapeutic Potentials of Immunometabolomic Modulations Induced by Tuberculosis Vaccination.
Rawat B, Kumar D, Soni V, Rosenn E
Vaccines (Basel). 2022; 10(12).
PMID: 36560537
PMC: 9781011.
DOI: 10.3390/vaccines10122127.
Cross-Generational Impact of Innate Immune Memory Following Pregnancy Complications.
Lodge-Tulloch N, Toews A, Atallah A, Cotechini T, Girard S, Graham C
Cells. 2022; 11(23).
PMID: 36497193
PMC: 9741472.
DOI: 10.3390/cells11233935.
Can BCG vaccination at first health-facility contact reduce early infant mortality? Study protocol for a cluster-randomised trial (CS-BCG).
Thysen S, Jensen A, Vedel J, Borges I, Aaby P, Jensen A
BMJ Open. 2022; 12(11):e063872.
PMID: 36410811
PMC: 9680145.
DOI: 10.1136/bmjopen-2022-063872.
Trained immunity is induced in humans after immunization with an adenoviral vector COVID-19 vaccine.
Murphy D, Cox D, Connolly S, Breen E, Brugman A, Phelan J
J Clin Invest. 2022; 133(2).
PMID: 36282571
PMC: 9843058.
DOI: 10.1172/JCI162581.